In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 7th, 2005 | 29 | Yes |
Popular Name: (Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol (Z)-4-(1-(4-(2-(Dimethylamino)et…
Find On: PubMed — Wikipedia — Google
CAS Numbers: 174592-47-3 , 65213-48-1 , 68047-06-3 , 68392-35-8 , [65213-48-1] , [68047-06-3]
(z)-4-(1-[4-(dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol
4-Hydroxytamoxifen; 68047-06-3; C05011; Hydroxytamoxifen
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.59 | 12.96 | -37.36 | 2 | 3 | 1 | 34 | 388.531 | 8 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | 95% | Fluorochem |
UniProt Database Links | ERR3_HUMAN; ERR3_MOUSE; ERR3_PONAB; GRAM4_HUMAN; SERA_HUMAN | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ERR3-1-E | Estrogen-related Receptor Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 13 | 0.38 | Binding ≤ 10μM |
ESR1-1-E | Estrogen Receptor Alpha (cluster #1 Of 5), Eukaryotic | Eukaryotes | 6 | 0.40 | Binding ≤ 10μM |
ESR2-1-E | Estrogen Receptor Beta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 32 | 0.36 | Binding ≤ 10μM |
PLD1-1-E | Phospholipase D1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4800 | 0.26 | Binding ≤ 10μM |
PLD2-1-E | Phospholipase D2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 44 | 0.36 | Binding ≤ 10μM |
ERR3-1-E | Estrogen-related Receptor Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 20 | 0.37 | Functional ≤ 10μM |
ESR1-1-E | Estrogen Receptor Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 7 | 0.39 | Functional ≤ 10μM |
ESR2-1-E | Estrogen Receptor Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7 | 0.39 | Functional ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 8000 | 0.25 | Functional ≤ 10μM |
Z80296-1-O | MVLN (cluster #1 Of 1), Other | Other | 3 | 0.41 | Functional ≤ 10μM |
Z80561-1-O | U2OS (Osteosarcoma Cells) (cluster #1 Of 1), Other | Other | 2 | 0.42 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 0.249 | 0.46 | Binding ≤ 1μM |
ESR1_RAT | P06211 | Estrogen Receptor Alpha, Rat | 6 | 0.40 | Binding ≤ 1μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 0.16 | 0.47 | Binding ≤ 1μM |
ESR2_RAT | Q62986 | Estrogen Receptor Beta, Rat | 6 | 0.40 | Binding ≤ 1μM |
ERR3_HUMAN | P62508 | Estrogen-related Receptor Gamma, Human | 13 | 0.38 | Binding ≤ 1μM |
PLD2_HUMAN | O14939 | Phospholipase D2, Human | 44 | 0.36 | Binding ≤ 1μM |
ESR1_RAT | P06211 | Estrogen Receptor Alpha, Rat | 6 | 0.40 | Binding ≤ 10μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 0.249 | 0.46 | Binding ≤ 10μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 0.16 | 0.47 | Binding ≤ 10μM |
ESR2_RAT | Q62986 | Estrogen Receptor Beta, Rat | 6 | 0.40 | Binding ≤ 10μM |
ERR3_HUMAN | P62508 | Estrogen-related Receptor Gamma, Human | 13 | 0.38 | Binding ≤ 10μM |
PLD1_HUMAN | Q13393 | Phospholipase D1, Human | 4800 | 0.26 | Binding ≤ 10μM |
PLD2_HUMAN | O14939 | Phospholipase D2, Human | 44 | 0.36 | Binding ≤ 10μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 0.1 | 0.48 | Functional ≤ 10μM |
ESR2_HUMAN | Q92731 | Estrogen Receptor Beta, Human | 0.1 | 0.48 | Functional ≤ 10μM |
ERR3_HUMAN | P62508 | Estrogen-related Receptor Gamma, Human | 15 | 0.38 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 0.1 | 0.48 | Functional ≤ 10μM |
Z80296 | Z80296 | MVLN | 3 | 0.41 | Functional ≤ 10μM |
Z80561 | Z80561 | U2OS (Osteosarcoma Cells) | 1.9 | 0.42 | Functional ≤ 10μM |
Description | Species |
---|---|
Nuclear Receptor transcription pathway | |
Nuclear signaling by ERBB4 | |
Role of phospholipids in phagocytosis | |
Synthesis of PA | |
Synthesis of PG |